Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (3) , 602-611
- https://doi.org/10.1038/mt.2010.222
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Influenza A Strain-Dependent Pathogenesis in Fatal H1N1 and H5N1 Subtype Infections of MiceEmerging Infectious Diseases, 2010
- Nanodisc-Incorporated Hemagglutinin Provides Protective Immunity against Influenza Virus InfectionJournal of Virology, 2010
- Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue EnvironmentPLOS ONE, 2009
- A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in miceBMC Infectious Diseases, 2009
- A consensus–hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza virusesProceedings of the National Academy of Sciences, 2008
- Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and MicePLOS ONE, 2008
- Electroporation-based DNA immunisation: translation to the clinicExpert Opinion on Biological Therapy, 2007
- Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnoverThe Journal of Experimental Medicine, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed HumansPLoS Medicine, 2007